BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34139370)

  • 1. Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape.
    Monedero-Recuero I; Gegia M; Wares DF; Chadha SS; Mirzayev F
    Int J Infect Dis; 2021 Jul; 108():557-567. PubMed ID: 34139370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
    Chakaya J; Khan M; Ntoumi F; Aklillu E; Fatima R; Mwaba P; Kapata N; Mfinanga S; Hasnain SE; Katoto PDMC; Bulabula ANH; Sam-Agudu NA; Nachega JB; Tiberi S; McHugh TD; Abubakar I; Zumla A
    Int J Infect Dis; 2021 Dec; 113 Suppl 1(Suppl 1):S7-S12. PubMed ID: 33716195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statement.
    Arora VK; Jindal SK; Katiyar SK; Behra D; Talwar D; Sarin R; Dhar R; Mehta P; Bhargava S; Singhal P; Joshi S; Tiwaskar M; Nikam C; Chatterjee A; Vora A
    Indian J Tuberc; 2023 Oct; 70(4):383-389. PubMed ID: 37968042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets.
    Sahu S; Ditiu L; Sachdeva KS; Zumla A
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S100-S103. PubMed ID: 33716198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study.
    Nalunjogi J; Mucching-Toscano S; Sibomana JP; Centis R; D'Ambrosio L; Alffenaar JW; Denholm J; Blanc FX; Borisov S; Danila E; Duarte R; García-García JM; Goletti D; Ong CWM; Rendon A; Thomas TA; Tiberi S; van den Boom M; Sotgiu G; Migliori GB;
    Int J Infect Dis; 2023 May; 130 Suppl 1():S25-S29. PubMed ID: 36893943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistant tuberculosis in Italy through a global health lens.
    Fama F; Genovese C; Raviglione M; Gori A
    New Microbiol; 2023 May; 46(2):120-132. PubMed ID: 37247232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review.
    Yusoof KA; García JI; Schami A; Garcia-Vilanova A; Kelley HV; Wang SH; Rendon A; Restrepo BI; Yotebieng M; Torrelles JB
    Front Immunol; 2022; 13():870768. PubMed ID: 35874762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China.
    Agnarson AM; Wang XC; Potluri R; Bhandari H; Dhir A; Kambili C; Metz L
    BMC Infect Dis; 2020 Feb; 20(1):113. PubMed ID: 32041542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
    PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluating the merits of decentralization as a core strategy for effective delivery of drug-resistant tuberculosis care in Pakistan.
    Khan U; Lotia-Farrukh I; Akhtar A; Khowaja SN; Khan S; Madhani F; Parekh A; Adnan S; Ahmed S; Chaudhry M; Hussain H; Habib A; Butt S; Siddiqui MR; Ijaz R; Jamal S; Khan AB; Keshavjee S; Khan AJ; Salahuddin N; Khan PY
    Health Policy Plan; 2022 Sep; 37(8):979-989. PubMed ID: 35527232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
    Shah I; Shah F
    Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward.
    Dean AS; Tosas Auguet O; Glaziou P; Zignol M; Ismail N; Kasaeva T; Floyd K
    Lancet Infect Dis; 2022 Jul; 22(7):e191-e196. PubMed ID: 35248168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance.
    Hameed S; Ahmad SR; Rahman MAU; Nazir H; Ullah I
    J Glob Antimicrob Resist; 2019 Sep; 18():155-159. PubMed ID: 30910744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
    PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Resistant Tuberculosis and COVID-19: A Scoping Review on a New Threat to Antimicrobial Resistance.
    Silva BPMD; Almeida AS; Sérgio MGM; Gatto TC; Carasek VP; Yamamura M
    Rev Bras Enferm; 2023; 76Suppl 1(Suppl 1):e20220803. PubMed ID: 38055430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant tuberculosis around the world: what progress has been made?
    Falzon D; Mirzayev F; Wares F; Baena IG; Zignol M; Linh N; Weyer K; Jaramillo E; Floyd K; Raviglione M
    Eur Respir J; 2015 Jan; 45(1):150-60. PubMed ID: 25261327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and patterns of drug resistant pulmonary tuberculosis in India-A systematic review and meta-analysis.
    Lohiya A; Suliankatchi Abdulkader R; Rath RS; Jacob O; Chinnakali P; Goel AD; Agrawal S
    J Glob Antimicrob Resist; 2020 Sep; 22():308-316. PubMed ID: 32247079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of DR-TB (drug-resistant tuberculosis): An Indicator of public health negligence.
    Masood R; Muhammad IN; Siddiqui T; Mushtaque M; Irshad A
    Pak J Pharm Sci; 2019 Jul; 32(4):1529-1536. PubMed ID: 31608871
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.